T J Montine Selected Research

manganese ethylenebis(dithiocarbamate)

1/2004

Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T J Montine Research Topics

Disease

16	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 08/2000
6	Parkinson Disease (Parkinson's Disease) 01/2004 - 01/2000
5	Dementia (Dementias) 09/2010 - 09/2000
5	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2007 - 02/2001
3	Amyloid Plaque 09/2010 - 07/2001
2	Cognitive Dysfunction 06/2016 - 08/2007
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 05/2007
2	Gliosis 06/2007 - 10/2001
2	Huntington Disease (Huntington's Disease) 06/2007 - 12/2000
2	Neuroblastoma 07/2001 - 03/2000
1	Vascular System Injuries 01/2018
1	Brain Ischemia (Cerebral Ischemia) 05/2009
1	Schizophrenia (Dementia Praecox) 05/2009
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2009
1	Prodromal Symptoms 08/2007
1	Synucleinopathies 05/2007
1	Parkinsonian Disorders (Parkinsonism) 01/2004
1	Movement Disorders (Movement Disorder) 01/2002
1	Infections 12/2000
1	Multiple System Atrophy 09/2000
1	Nervous System Diseases (Neurological Disorders) 03/2000

Drug/Important Bio-Agent (IBA)

4	Apolipoproteins E (ApoE)IBA 01/2016 - 08/2000
4	Lipoproteins (Lipoprotein)IBA 01/2003 - 08/2000
3	Proteins (Proteins, Gene)FDA Link 06/2016 - 02/2001
3	ApolipoproteinsIBA 12/2013 - 08/2000
3	Dopamine (Intropin)FDA LinkGeneric 12/2001 - 03/2000
2	Oxidoreductases (Dehydrogenase)IBA 08/2007 - 07/2001
2	Biomarkers (Surrogate Marker)IBA 08/2007 - 04/2001
2	Acetylcysteine (Siran)FDA LinkGeneric 12/2001 - 11/2001
2	5-S-cysteinyldopamineIBA 12/2001 - 11/2001
2	F2-Isoprostanes (F2 Isoprostanes)IBA 04/2001 - 12/2000
2	NeuroprostanesIBA 01/2001 - 01/2001
2	IsoprostanesIBA 01/2001 - 01/2001
2	catechol (pyrocatechol)IBA 08/2000 - 03/2000
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2016
1	tau Proteins (tau Protein)IBA 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2010
1	Prostaglandins EIBA 05/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2007
1	Indicators and Reagents (Reagents)IBA 08/2007
1	CalbindinsIBA 06/2007
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 06/2007
1	ProgranulinsIBA 05/2007
1	ManebIBA 01/2004
1	manganese ethylenebis(dithiocarbamate)IBA 01/2004
1	Mitochondrial DNA (mtDNA)IBA 01/2002
1	Protein Isoforms (Isoforms)IBA 01/2002
1	LipidsIBA 01/2002
1	Levodopa (L Dopa)FDA LinkGeneric 11/2001
1	EnzymesIBA 11/2001
1	AldehydesIBA 10/2001
1	4-hydroxybutyrate dehydrogenaseIBA 10/2001
1	AntioxidantsIBA 10/2001
1	Peptides (Polypeptides)IBA 07/2001
1	Aldehyde Reductase (Aldose Reductase)IBA 07/2001
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 07/2001
1	IsoenzymesIBA 07/2001
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2001
1	Free RadicalsIBA 04/2001
1	Acrolein (Aqualin)IBA 02/2001
1	AntigensIBA 12/2000
1	EpitopesIBA 09/2000
1	alpha-SynucleinIBA 09/2000
1	AntibodiesIBA 09/2000
1	Oxidants (Oxidizing Agents)IBA 03/2000
1	CatecholsIBA 03/2000
1	3,4-Dihydroxyphenylacetic AcidIBA 03/2000
1	Sulfides (Thioethers)IBA 03/2000
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2000

Therapy/Procedure

2	Therapeutics 08/2007 - 08/2007
1	Transplantation 06/2007
1	Tissue Transplantation 06/2007